IHT Wealth Management’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,463
Closed -$250K 1281
2025
Q4
$250K Buy
+2,463
New +$198K 0.01% 1028
2025
Q3
Sell
-4,292
Closed -$228K 1186
2025
Q2
$228K Buy
+4,292
New +$218K 0.01% 1028
2025
Q1
Sell
-4,353
Closed -$245K 1103
2024
Q4
$245K Sell
4,353
-129
-3% -$8.03K 0.01% 934
2024
Q3
$305K Buy
+4,482
New +$253K 0.01% 907
2024
Q2
Sell
-6,871
Closed -$475K 1039
2024
Q1
$475K Sell
6,871
-13
-0.2% -$822 0.02% 660
2023
Q4
$509K Buy
6,884
+109
+2% +$7.14K 0.02% 593
2023
Q3
$462K Sell
6,775
-111
-2% -$9.42K 0.02% 581
2023
Q2
$647K Sell
6,886
-21
-0.3% -$1.64K 0.03% 465
2023
Q1
$468K Buy
6,907
+12
+0.2% +$771 0.03% 519
2022
Q4
$341K Hold
6,895
0.02% 603
2022
Q3
$224K Buy
6,895
+540
+8% +$22.3K 0.02% 740
2022
Q2
$250K Sell
6,355
-23
-0.4% -$1.23K 0.02% 588
2022
Q1
$446K Sell
6,378
-250
-4% -$18.3K 0.03% 441
2021
Q4
$516K Buy
6,628
+725
+12% +$64K 0.04% 427
2021
Q3
$563K Buy
5,903
+352
+6% +$37.2K 0.05% 389
2021
Q2
$690K Buy
5,551
+388
+8% +$46.3K 0.04% 417
2021
Q1
$680K Buy
5,163
+999
+24% +$137K 0.05% 367
2020
Q4
$552K Sell
4,164
-770
-16% -$93.1K 0.05% 373
2020
Q3
$503K Sell
4,934
-684
-12% -$59.1K 0.05% 346
2020
Q2
$488K Buy
5,618
+1,025
+22% +$81.9K 0.07% 297
2020
Q1
$266K Buy
4,593
+658
+17% +$53.4K 0.04% 421
2019
Q4
$364K Buy
3,935
+402
+11% +$35.3K 0.04% 396
2019
Q3
$319K Buy
3,533
+500
+16% +$57K 0.04% 410
2019
Q2
$358K Sell
3,033
-60
-2% -$6.05K 0.05% 362
2019
Q1
$268K Buy
+3,093
New +$263K 0.04% 385
2018
Q4
Sell
-3,000
Closed -$237K 487
2018
Q3
$237K Buy
+3,000
New +$196K 0.05% 372
2018
Q2
Sell
-3,077
Closed -$119K 726
2018
Q1
$119K Sell
3,077
-573
-16% -$28K 0.03% 444
2017
Q4
$182K Buy
3,650
+3,150
+630% +$168K 0.05% 366
2017
Q3
$24K Hold
500
0.01% 717
2017
Q2
$16 Buy
+500
New +$15.4K 0.01% 835

Other funds holding EXAS

IHT Wealth Management's EXAS Position: Q1 2026 in Review

IHT Wealth Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 2,463 shares — an estimated $250K sold.

IHT Wealth Management first reported a position in EXAS in Q2 2017 and held it in 30 quarters. The position peaked at $690K in Q2 2021. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • IHT Wealth Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • IHT Wealth Management sold 2,463 Exact Sciences shares in Q1 2026, an estimated $250K.
  • IHT Wealth Management first reported a position in Exact Sciences in Q2 2017 and held it in 30 quarters.
  • IHT Wealth Management's Exact Sciences position peaked at $690K in Q2 2021.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on IHT Wealth Management's 13F filing for Q1 2026, filed 15 May 2026.